Patients often visit their primary care provider hoping to find relief from physical pain. When a physiological origin cannot be identified, one hypothesis suggests depression is responsible for the pain. Depression screening is recommended for those experiencing unexplained pain because the diagnosis may be depression-pain syndrome. A treatment plan using both pharmacologic agents and psychotherapy is suggested; however, these may not fully resolve all symptoms. Providers should be knowledgeable about complementary/alternative therapies. A balanced combination of conventional and complementary/alternative medical services can enhance treatment and provide practical tools to improve the quality of life for a patient with depression-pain syndrome.
American Massage Therapy Association. (2004). AMTA definition of massage therapy. Retrieved November 19, 2004, from http://www.amtamassage.org/about/definition.html
2.
American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., text revision). Washington, DC: Author.
3.
Bair, M. J., Robinson, R., Katon, W., & Kroenke, K. (2003). Depression and pain comorbidity. Archives of Internal Medicine, 163, 2433-2445.
4.
Beck, A. T., Steer, R. A., & Brown, G. K. (1996). Beck Depression Inventory-II. San Antonio, TX: Harcourt Assessment.
5.
Beck, A.T., Ward, C.H., Mendelson, M., Mock, J.,& Erbaugh, J. (1961). An inventory for measuring depression. Archives of General Psychiatry, 4, 561-571.
6.
Beckman, T. (2003). Discussing the depression-pain dyad with patients. Archives of Internal Medicine, 164, 804-805.
7.
Eisenberg, D.M., Davis, R.B., Ettner, S.L., Appel, S., Wilkey, S.,&Van Rompay, M. (1998). Trends in alternative medicine use in the United States, 1990-1997. Journal of the American Medical Association, 280, 1569-1575.
8.
Eisenberg, D.M., Kessler, R.C., Foster, C., Norlock, F.E., Calkins, R., & Delbanco, T. L. (1993). Unconventional medicine in the United States-prevalence, costs and patterns of use. New England Journal of Medicine, 328, 246-252.
9.
Emanuel, A. M., Moore, T. R., & Ghazvini, P. (2001). Considerations for the use of alternative therapies in the treatment of depression. Journal of Pharmacy Practice, 14, 551-559.
10.
Field, T., Diego, M., Cullen, C., Hernandez-Reif, M., Sunshine, W., & Douglas, S. (2002). Fibromyalgia pain and substance p decrease and sleep improves after massage therapy. Journal of Clinical Rheumatology, 8(2), 72-76.
11.
Goldhagen, H. (1998). Alternative medical web sites. Infective Medicine, 15, 309-313.
12.
Goroll, A. H., & Mulley, A. G. (2000). Primary care medicine (4th ed.). Philadelphia: Lippincott Williams & Wilkins.
13.
Hamilton, M. (1960). A rating scale for depression. Journal of Neurology, Neurosurgery & Psychiatry, 23, 56-62.
14.
Khouzam, H. R. (2000). Chronic pain and its management in primary care. Southern Medical Journal, 93, 946-952.
15.
Lawson, K.L.,& Horneffer, K. (2002). Roots and wings. Journal of Holistic Nursing, 20, 250-263.
16.
Montgomery, S. A., & Asberg, M. (1979). A new depression scale designed to be sensitive to change. British Journal of Psychiatry, 134, 382-389.
17.
Nanke, A., & Winfried, R. (2004). Biofeedback in somatoform disorders and related syndromes. Current Opinion in Psychiatry, 17, 133-135.
18.
National Institute of Mental Health. (2001). The numbers count: Mental disorders in America (NIH Publication No. 01-4584). Retrieved October 11, 2004, from http://www.nimh.nih.gov
19.
Nease, D.E., Volk, R.J.,& Cass, A.R. (1999). Investigation of a severity-based classification of mood and anxiety symptoms in primary care patients. Journal of the American Board of Family Practice, 12(1), 21-31.
20.
Ott, M. J. (2002). Mindfulness meditation in pediatric clinical practice. Pediatric Nursing, 28, 487-535.
21.
Patrick, G. (2002). Biofeedback applications for psychiatric nursing. Journal of the American Psychiatric Nurses Association, 8, 109-113.
22.
Phillips, W. T., Kernan, M., & King, A. C. (2003). Physical activity as a nonpharmacological treatment for depression: A review. Complementary Health Practice Review, 8, 139-152.
23.
Ricciuti, J. S. (2004). Food and Drug Administration approvals. Medscape Pharmacists, 5(2), 2004. Retrieved October 26, 2004, from Medscape Database.
24.
Rush, A.J., Giles, D.E., Schlesser, M.A., Fulton, C.L., Weissenburger, J., & Burns, C. (1986). The Inventory for Depressive Symptomatology (IDS): Preliminary findings.Psychiatry Research, 18, 65-87.
25.
Simon, G. (1998). Can depression be managed appropriately in primary care?Journal of Clinical Psychiatry, 59(Suppl. 2), 3-8.
26.
Stahl, S. M. (2003). Essential psychopharmacology: Neuroscientific basis and practical application (2nd ed.). New York: Cambridge University Press.
27.
Wehner, J. S., & Stoner, S. C. (2001). Tools and techniques for evaluating depression. Journal of Pharmacy Practice, 14, 448-452.
28.
Zimmerman, M. (1994). Interview guide for evaluating DSM-IV psychiatric disorders and the mental status examination. East Greenwich, RI: Psych Products Press.
29.
Zung, W. W. (1965). A self-rating depression scale. Archives of General Psychiatry, 12, 63-70.
30.
Zunkel, G. M. (2003). Depressive disorders: Treatment with nonpharmacological alternatives. Complementary Health Practice Review, 8, 116-127.
